Oventus Overview

Founded 2012
Status Public
Employees 11
Stock Symbol OVN
Stock Symbol
Share Price $0.17 (As of Friday Closing)

Oventus General Information


Oventus Medical Ltd is a medical device company. It is engaged in developing oral appliance for the treatment of sleep apnoea and snoring. Its products include O2Vent Mono and O2Vent.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Stock Exchange
Primary Office
  • PO Box 190
  • Indooroopilly, Queensland 4068
  • Australia
+61 (07) 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oventus Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.17 $0.16 $0.10 - $0.62 $25.1M 150M 335K

Oventus Financials Summary

In Thousands,
TTM 31-Mar-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018 FY 2017 30-Jun-2017
Enterprise Value 15,482 12,134 15,258 16,177
Revenue 237 210 338
EBITDA (5,173) (4,109) (4,509)
Net Income (5,612) (4,547) (4,906)
Total Assets 6,275 11,616 10,850
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Oventus Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oventus‘s full profile, request access.

Request a free trial

Oventus Executive Team (2)

Name Title Board Seat Contact Info
Neil Anderson Chief Executive Officer & Managing Director
Chris Hart Founder and Clinical Director

Oventus Board Members (1)

Name Representing Role Since
Mel Bridges Oventus Chairman 000 0000